Skip to main content
Log in

Cardioprotective action of Amaranthus viridis methanolic extract and its isolated compound Kaempferol through mitigating lipotoxicity, oxidative stress and inflammation in the heart

  • Original Article
  • Published:
3 Biotech Aims and scope Submit manuscript

Abstract

The current study was designed to evaluate the cardio-protective efficacy of Amaranthus viridis L. methanolic extract (AVME) and kaempferol, which was isolated from AVME in isoproterenol (ISO)-induced cardiotoxicity in rats. The rats were pre-treated with AVME (250 mg/kg body weight) and kaempferol (50 mg/kg BW) for 30 days, respectively, and then administered with ISO (20 mg/100 g body weight) on the 31st and 32nd days. We assessed the protective effects of AVME and kaempferol against ISO-induced cardiotoxicity, oxidative stress, and inflammation. The study revealed that supplementation with AVME and kaempferol significantly attenuated cardiac lipotoxicity by reducing cholesterol and triglyceride levels and simultaneously increasing the levels of high-density lipoproteins. In addition, AVME and kaempferol suppressed oxidative stress by enhancing the activities of superoxide dismutase, catalase, and glutathione peroxidase in the heart. Further, they ameliorated cardiac inflammation by mitigating the production of pro-inflammatory cytokines (tumor necrosis factor-alpha, interleukin-6, and interleukin-1β). Hence, the study results and histopathological analysis emphasized that AVME and kaempferol could be prospective prophylactic agents against ISO-induced cardiotoxicity and may be considered nutraceuticals in the prevention of cardiovascular disorders.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8
Fig. 9

Similar content being viewed by others

Data availability

Data is available with the corresponding author, if required.

References

Download references

Funding

This research received funding from DST-SERB Project, UGC-Centre with Potential for Excellence in Particular Area (CPEPA) by RRA and the infrastructure facilities was partially supported by DST PURSE 2.0, Department of Science and Technology, Government of India. The fellowship was provided by UGC-RGNF, New Delhi to RKN (Fellowship No: 202021-NFST-TEL-00696; dt: 20–09-2021).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Roja Rani Anupalli.

Ethics declarations

Conflict of interest

The author(s) declare no conflicts of interest with respect to the research, authorship, and/or publication of this article.

ethical statement

The authors declare that no experiments were performed on humans. All studies of animal experiments were approved by the Institutional Animal Ethical Committee (IAEC), Jeeva Life Sciences in Hyderabad, Telangana, India (Approval No: CPCSEA/IAEC/JLS/14/02/21/80).

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Krishna, P.S., Nenavath, R.K., Sudha Rani, S. et al. Cardioprotective action of Amaranthus viridis methanolic extract and its isolated compound Kaempferol through mitigating lipotoxicity, oxidative stress and inflammation in the heart. 3 Biotech 13, 317 (2023). https://doi.org/10.1007/s13205-023-03680-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s13205-023-03680-2

Keywords

Navigation